BioVie Inc.
FORMULATIONS OF TERLIPRESSIN
Last updated:
Abstract:
The disclosure provides pharmaceutical compositions comprising terlipressin having increased concentration with long term storage stability.
Status:
Application
Type:
Utility
Filling date:
22 May 2020
Issue date:
28 Jul 2022